Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 829

1.

Glycemic Control After Kidney Transplantation Using Sensor-augmented Insulin Pump Therapy in a Patient with Slowly Progressive Type 1 Diabetes Mellitus.

Kaneyama N, Toyoda M, Kato E, Ono M, Saito N, Kimura M, Nakamura M, Fukagawa M.

Tokai J Exp Clin Med. 2020 Apr 20;45(1):49-52.

PMID:
32219809
2.

Rapamycin promotes endothelial-mesenchymal transition during stress-induced premature senescence through the activation of autophagy.

Sasaki N, Itakura Y, Toyoda M.

Cell Commun Signal. 2020 Mar 12;18(1):43. doi: 10.1186/s12964-020-00533-w.

3.

Mutations of histone demethylase genes encoded by X and Y chromosomes, Kdm5c and Kdm5d, lead to noncompaction cardiomyopathy in mice.

Kosugi M, Otani M, Kikkawa Y, Itakura Y, Sakai K, Ito T, Toyoda M, Sekita Y, Kimura T.

Biochem Biophys Res Commun. 2020 Feb 17. pii: S0006-291X(20)30311-9. doi: 10.1016/j.bbrc.2020.02.043. [Epub ahead of print]

PMID:
32081420
4.

Amrubicin for Patients With Platinum-refractory Small-cell Prostate Cancer: Two Case Reports.

Suzuki K, Terakawa T, Kimbara S, Toyoda M, Jimbo N, Nakano Y, Minami H, Fujisawa M.

Clin Genitourin Cancer. 2020 Jan 7. pii: S1558-7673(19)30390-8. doi: 10.1016/j.clgc.2019.12.017. [Epub ahead of print] No abstract available.

PMID:
32005612
5.

Polymeric modification of gemcitabine via cyclic acetal linkage for enhanced anticancer potency with negligible side effects.

Takemoto H, Inaba T, Nomoto T, Matsui M, Liu X, Toyoda M, Honda Y, Taniwaki K, Yamada N, Kim J, Tomoda K, Nishiyama N.

Biomaterials. 2020 Mar;235:119804. doi: 10.1016/j.biomaterials.2020.119804. Epub 2020 Jan 22.

PMID:
31991339
6.

Vascular Diseases and Gangliosides.

Sasaki N, Toyoda M.

Int J Mol Sci. 2019 Dec 17;20(24). pii: E6362. doi: 10.3390/ijms20246362. Review.

7.

Ganglioside GM2, highly expressed in the MIA PaCa-2 pancreatic ductal adenocarcinoma cell line, is correlated with growth, invasion, and advanced stage.

Sasaki N, Hirabayashi K, Michishita M, Takahashi K, Hasegawa F, Gomi F, Itakura Y, Nakamura N, Toyoda M, Ishiwata T.

Sci Rep. 2019 Dec 18;9(1):19369. doi: 10.1038/s41598-019-55867-4.

8.

Mayer-Type Optimal Control of Probabilistic Boolean Control Network With Uncertain Selection Probabilities.

Toyoda M, Wu Y.

IEEE Trans Cybern. 2019 Dec 16. doi: 10.1109/TCYB.2019.2954849. [Epub ahead of print]

PMID:
31841429
9.

Characterization of the metastatic potential of the floating cell component of MIA PaCa-2, a human pancreatic cancer cell line.

Sasaki N, Gomi F, Hasegawa F, Hirano K, Fujiwara M, Toyoda M, Ishiwata T.

Biochem Biophys Res Commun. 2020 Feb 19;522(4):881-888. doi: 10.1016/j.bbrc.2019.11.120. Epub 2019 Dec 2.

PMID:
31806369
10.

Relation between Blood Pressure Management and Renal Effects of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Patients with Chronic Kidney Disease.

Kobayashi K, Toyoda M, Kaneyama N, Hatori N, Furuki T, Sakai H, Takihata M, Umezono T, Ito S, Suzuki D, Takeda H, Kanamori A, Degawa H, Yamamoto H, Machimura H, Mokubo A, Chin K, Obana M, Hishiki T, Aoyama K, Nakajima S, Umezawa S, Shimura H, Aoyama T, Miyakawa M.

J Diabetes Res. 2019 Nov 3;2019:9415313. doi: 10.1155/2019/9415313. eCollection 2019.

11.

A Case of Multi-System Langerhans Cell Histiocytosis with Local Invasion of the Orbital Apex.

Yamada H, Kurimoto T, Mori S, Sakamoto M, Ueda K, Yamada-Nakanishi Y, Uozumi Y, Shose H, Taniguchi M, Toyoda M, Minami H, Nakamura M.

Case Rep Ophthalmol. 2019 Sep 19;10(3):319-326. doi: 10.1159/000502946. eCollection 2019 Sep-Dec.

12.

Factors related to suboptimal recovery of renal function after living donor nephrectomy: a retrospective study.

Nishida S, Hidaka Y, Toyoda M, Kinoshita K, Tanaka K, Kawabata C, Hamanoue S, Inadome A, Yokomizo H, Takeda A, Uekihara S, Yamanaga S.

BMC Nephrol. 2019 Nov 8;20(1):403. doi: 10.1186/s12882-019-1588-3.

13.

Natural HIV-1 Nef Polymorphisms Impair SERINC5 Downregulation Activity.

Jin SW, Alsahafi N, Kuang XT, Swann SA, Toyoda M, Göttlinger H, Walker BD, Ueno T, Finzi A, Brumme ZL, Brockman MA.

Cell Rep. 2019 Nov 5;29(6):1449-1457.e5. doi: 10.1016/j.celrep.2019.10.007.

14.

Imlifidase Inhibits HLA Antibody-Mediated NK Cell Activation and Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC) In Vitro.

Ge S, Chu M, Choi J, Louie S, Vo A, Jordan SC, Toyoda M.

Transplantation. 2019 Oct 21. doi: 10.1097/TP.0000000000003023. [Epub ahead of print]

PMID:
31644495
15.

Development and Validation of the Continuous Subcutaneous Insulin Infusion-Related Quality-of-Life (CSII-QOL) Scale.

Sakane N, Murata T, Tone A, Kato K, Kimura M, Kawashima S, Sawaki H, Hirota Y, Okada A, Kuroda A, Matsuhisa M, Watanabe T, Suganuma A, Nirengi S, Toyoda M.

Diabetes Technol Ther. 2020 Mar;22(3):216-221. doi: 10.1089/dia.2019.0216.

PMID:
31638420
16.

NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods.

De Leoz MLA, Duewer DL, Fung A, Liu L, Yau HK, Potter O, Staples GO, Furuki K, Frenkel R, Hu Y, Sosic Z, Zhang P, Altmann F, Gru Nwald-Grube C, Shao C, Zaia J, Evers W, Pengelley S, Suckau D, Wiechmann A, Resemann A, Jabs W, Beck A, Froehlich JW, Huang C, Li Y, Liu Y, Sun S, Wang Y, Seo Y, An HJ, Reichardt NC, Ruiz JE, Archer-Hartmann S, Azadi P, Bell L, Lakos Z, An Y, Cipollo JF, Pucic-Bakovic M, Štambuk J, Lauc G, Li X, Wang PG, Bock A, Hennig R, Rapp E, Creskey M, Cyr TD, Nakano M, Sugiyama T, Leung PA, Link-Lenczowski P, Jaworek J, Yang S, Zhang H, Kelly T, Klapoetke S, Cao R, Kim JY, Lee HK, Lee JY, Yoo JS, Kim SR, Suh SK, de Haan N, Falck D, Lageveen-Kammeijer GSM, Wuhrer M, Emery RJ, Kozak RP, Liew LP, Royle L, Urbanowicz PA, Packer NH, Song X, Everest-Dass A, Lattová E, Cajic S, Alagesan K, Kolarich D, Kasali T, Lindo V, Chen Y, Goswami K, Gau B, Amunugama R, Jones R, Stroop CJM, Kato K, Yagi H, Kondo S, Yuen CT, Harazono A, Shi X, Magnelli PE, Kasper BT, Mahal L, Harvey DJ, O'Flaherty R, Rudd PM, Saldova R, Hecht ES, Muddiman DC, Kang J, Bhoskar P, Menard D, Saati A, Merle C, Mast S, Tep S, Truong J, Nishikaze T, Sekiya S, Shafer A, Funaoka S, Toyoda M, de Vreugd P, Caron C, Pradhan P, Tan NC, Mechref Y, Patil S, Rohrer JS, Chakrabarti R, Dadke D, Lahori M, Zou C, Cairo C, Reiz B, Whittal RM, Lebrilla CB, Wu L, Guttman A, Szigeti M, Kremkow BG, Lee KH, Sihlbom C, Adamczyk B, Jin C, Karlsson NG, Örnros J, Larson G, Nilsson J, Meyer B, Wiegandt A, Komatsu E, Perreault H, Bodnar ED, Said N, Francois YN, Leize-Wagner E, Maier S, Zeck A, Heck AJR, Yang Y, Haselberg R, Yu YQ, Alley W, Leone JW, Yuan H, Stein SE.

Mol Cell Proteomics. 2020 Jan;19(1):11-30. doi: 10.1074/mcp.RA119.001677. Epub 2019 Oct 7.

17.

Nivolumab-induced fulminant type 1 diabetes with precipitous fall in C-peptide level.

Miyauchi M, Toyoda M, Zhang J, Hamada N, Yamawaki T, Tanaka J, Harada K, Kashizaki F, Fukagawa M.

J Diabetes Investig. 2019 Oct 6. doi: 10.1111/jdi.13143. [Epub ahead of print]

18.

Caution is required for the evaluation of the accuracy of continuous glucose monitoring devices.

Hirota Y, Toyoda M, Murata T, Miura J.

J Diabetes Investig. 2020 Jan;11(1):255. doi: 10.1111/jdi.13149. Epub 2019 Oct 1. No abstract available.

19.

Frequent retrotransposition of endogenous genes in ERCC2-deficient cells derived from a patient with xeroderma pigmentosum.

Aoto S, Katagiri S, Wang Y, Pagnamenta AT, Sakamoto-Abutani R, Toyoda M, Umezawa A, Okamura K.

Stem Cell Res Ther. 2019 Aug 27;10(1):273. doi: 10.1186/s13287-019-1381-z.

20.

On Optimal Time-Varying Feedback Controllability for Probabilistic Boolean Control Networks.

Toyoda M, Wu Y.

IEEE Trans Neural Netw Learn Syst. 2019 Aug 1. doi: 10.1109/TNNLS.2019.2927241. [Epub ahead of print]

PMID:
31395555
21.

Modelling and in vitro testing of the HIV-1 Nef fitness landscape.

Barton JP, Rajkoomar E, Mann JK, Murakowski DK, Toyoda M, Mahiti M, Mwimanzi P, Ueno T, Chakraborty AK, Ndung'u T.

Virus Evol. 2019 Aug 5;5(2):vez029. doi: 10.1093/ve/vez029. eCollection 2019 Jul.

22.

Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients with Chronic Antibody-Mediated Rejection.

Shin BH, Everly MJ, Zhang H, Choi J, Vo A, Zhang X, Huang E, Jordan SC, Toyoda M.

Transplantation. 2019 Aug 1. doi: 10.1097/TP.0000000000002895. [Epub ahead of print]

PMID:
31385933
23.
24.

Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture.

Shichi Y, Sasaki N, Michishita M, Hasegawa F, Matsuda Y, Arai T, Gomi F, Aida J, Takubo K, Toyoda M, Yoshimura H, Takahashi K, Ishiwata T.

Sci Rep. 2019 Jul 26;9(1):10871. doi: 10.1038/s41598-019-47416-w.

25.

Prediction model of compensation for contralateral kidney after living-donor donation.

Okumura K, Yamanaga S, Tanaka K, Kinoshita K, Kaba A, Fujii M, Ogata M, Hidaka Y, Toyoda M, Uekihara S, Miyata A, Inadome A, Yokomizo H.

BMC Nephrol. 2019 Jul 26;20(1):283. doi: 10.1186/s12882-019-1464-1.

26.

The Effect of High-concentration Insulin Glarigine on the Quality of Life of Patients with Type 2 Diabetes Mellitus: A Pre-post Study (HIGH-QOL STUDY).

Murata T, Tone A, Kouyama R, Kamiuchi K, Narasaki K, Tsuruo M, Watanabe T, Kawashima S, Kato K, Sawaki H, Osawa K, Kimura M, Toyoda M, Suganuma A, Sakane N; HIGH-QOL study group.

Intern Med. 2019 Oct 15;58(20):2943-2948. doi: 10.2169/internalmedicine.1794-18. Epub 2019 Jun 27.

27.

The C-terminal flexible region of branched-chain polyamine synthase facilitates substrate specificity and catalysis.

Hidese R, Toyoda M, Yoshino KI, Fukuda W, Wihardja GA, Kimura S, Fujita J, Niitsu M, Oshima T, Imanaka T, Mizohata E, Fujiwara S.

FEBS J. 2019 Oct;286(19):3926-3940. doi: 10.1111/febs.14949. Epub 2019 Jun 21.

PMID:
31162806
28.

Effect of Serum Parathyroid Hormone on Tacrolimus Therapy in Kidney Transplant Patients: A Possible Biomarker for a Tacrolimus Dosage Schedule.

Hirata K, Watanabe H, Toyoda M, Sugimoto R, Ikegami K, Imafuku T, Matsuzaka K, Ichimizu S, Maeda H, Uekihara S, Jingami S, Maruyama T.

Biol Pharm Bull. 2019;42(5):786-791. doi: 10.1248/bpb.b18-00976.

29.

Prior cycling exercise does not prevent endothelial dysfunction after resistance exercise.

Morishima T, Toyoda M, Ochi E.

Eur J Appl Physiol. 2019 Jul;119(7):1663-1669. doi: 10.1007/s00421-019-04154-1. Epub 2019 May 4.

PMID:
31055679
30.

Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers.

Sasaki N, Toyoda M, Hasegawa F, Fujiwara M, Gomi F, Ishiwata T.

Biochem Biophys Res Commun. 2019 Jun 18;514(1):112-117. doi: 10.1016/j.bbrc.2019.04.117. Epub 2019 Apr 23.

PMID:
31027735
31.

Chronic Renal Failure as a Possible Risk Factor for Allergic Reaction in Therapeutic Plasma Exchange Using Fresh Frozen Plasma.

Eguchi M, Okumura K, Torigoe K, Toyoda M, Uekihara S, Yamanaga S.

Ther Apher Dial. 2019 Jun;23(3):261-265. doi: 10.1111/1744-9987.12823. Epub 2019 May 26.

PMID:
31026119
32.

Comparison of functional glycans between cancer stem cells and normal stem cells.

Sasaki N, Itakura Y, Gomi F, Hirano K, Toyoda M, Ishiwata T.

Histol Histopathol. 2019 Sep;34(9):995-1007. doi: 10.14670/HH-18-119. Epub 2019 Apr 26. Review.

PMID:
31025698
33.

Gangliosides Contribute to Vascular Insulin Resistance.

Sasaki N, Itakura Y, Toyoda M.

Int J Mol Sci. 2019 Apr 12;20(8). pii: E1819. doi: 10.3390/ijms20081819. Review.

34.

Exploratory analysis of prognostic factors for lenvatinib in radioiodine-refractory differentiated thyroid cancer.

Suzuki C, Kiyota N, Imamura Y, Goto H, Suto H, Chayahara N, Toyoda M, Ito Y, Miya A, Miyauchi A, Otsuki N, Nibu KI, Minami H.

Head Neck. 2019 Sep;41(9):3023-3032. doi: 10.1002/hed.25784. Epub 2019 Apr 23.

PMID:
31013380
35.

Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.

Arase Y, Shiraishi K, Anzai K, Sato H, Teramura E, Tsuruya K, Hirose S, Deguchi R, Toyoda M, Mine T, Kagawa T.

Clin Drug Investig. 2019 Jul;39(7):631-641. doi: 10.1007/s40261-019-00785-6.

36.

A practical method of liberating O-linked glycans from glycoproteins using hydroxylamine and an organic superbase.

Kameyama A, Thet Tin WW, Toyoda M, Sakaguchi M.

Biochem Biophys Res Commun. 2019 May 21;513(1):186-192. doi: 10.1016/j.bbrc.2019.03.144. Epub 2019 Apr 2.

37.

N-Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR ≥ 30 ml/min/1.73 m2.

Nitta K, Nagai T, Mizunuma Y, Kitada M, Nakagawa A, Sakurai M, Toyoda M, Haneda M, Kanasaki K, Koya D.

Clin Exp Nephrol. 2019 Aug;23(8):1004-1012. doi: 10.1007/s10157-019-01733-6. Epub 2019 Apr 4.

PMID:
30949886
38.

A Liquid-Based Cytology System, without the Use of Cytocentrifugation, for Detection of Podocytes in Urine Samples of Patients with Diabetic Nephropathy.

Kimura M, Toyoda M, Saito N, Kaneyama N, Miyatake H, Tanaka E, Komaba H, Hara M, Fukagawa M.

J Diabetes Res. 2019 Feb 17;2019:9475637. doi: 10.1155/2019/9475637. eCollection 2019.

39.

Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE).

Chayahara N, Mukohara T, Tachihara M, Fujishima Y, Fukunaga A, Washio K, Yamamoto M, Nakata K, Kobayashi K, Takenaka K, Toyoda M, Kiyota N, Tobimatsu K, Doi H, Mizuta N, Marugami N, Kawaguchi A, Nishigori C, Nishimura Y, Minami H.

Oncologist. 2019 Jul;24(7):885-e413. doi: 10.1634/theoncologist.2019-0156. Epub 2019 Mar 19.

40.

Metal Ions in Activated Carbon Improve the Detection Efficiency of Aflatoxin-Producing Fungi.

Suzuki T, Toyoda M.

Toxins (Basel). 2019 Mar 2;11(3). pii: E140. doi: 10.3390/toxins11030140.

41.

Quantification of hemodynamic irregularity using oscillatory velocity index in the associations with the rupture status of cerebral aneurysms.

Tanioka S, Ishida F, Kishimoto T, Tsuji M, Tanaka K, Shimosaka S, Toyoda M, Kashiwagi N, Sano T, Suzuki H.

J Neurointerv Surg. 2019 Jun;11(6):614-617. doi: 10.1136/neurintsurg-2018-014489. Epub 2019 Jan 22.

PMID:
30670624
42.

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.

Hayashi H, Kurata T, Takiguchi Y, Arai M, Takeda K, Akiyoshi K, Matsumoto K, Onoe T, Mukai H, Matsubara N, Minami H, Toyoda M, Onozawa Y, Ono A, Fujita Y, Sakai K, Koh Y, Takeuchi A, Ohashi Y, Nishio K, Nakagawa K.

J Clin Oncol. 2019 Mar 1;37(7):570-579. doi: 10.1200/JCO.18.00771. Epub 2019 Jan 17.

PMID:
30653423
43.

A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.

Taira M, Imamura M, Takahashi A, Kamatani Y, Yamauchi T, Araki SI, Tanaka N, van Zuydam NR, Ahlqvist E, Toyoda M, Umezono T, Kawai K, Imanishi M, Watada H, Suzuki D, Maegawa H, Babazono T, Kaku K, Kawamori R; SUMMIT Consortium, Groop LC, McCarthy MI, Kadowaki T, Maeda S.

PLoS One. 2018 Dec 19;13(12):e0208654. doi: 10.1371/journal.pone.0208654. eCollection 2018.

44.

Epigenetic-scale comparison of human iPSCs generated by retrovirus, Sendai virus or episomal vectors.

Nishino K, Arai Y, Takasawa K, Toyoda M, Yamazaki-Inoue M, Sugawara T, Akutsu H, Nishimura K, Ohtaka M, Nakanishi M, Umezawa A.

Regen Ther. 2018 Sep 1;9:71-78. doi: 10.1016/j.reth.2018.08.002. eCollection 2018 Dec.

45.

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma.

Hyogo Y, Kiyota N, Otsuki N, Goto S, Imamura Y, Chayahara N, Toyoda M, Nibu KI, Hyodo T, Hara S, Masuoka H, Kasahara T, Ito Y, Miya A, Hirokawa M, Miyauchi A, Minami H.

Case Rep Oncol. 2018 Nov 12;11(3):735-741. doi: 10.1159/000494080. eCollection 2018 Sep-Dec.

46.

A phase I study of single-agent BEZ235 special delivery system sachet in Japanese patients with advanced solid tumors.

Toyoda M, Watanabe K, Amagasaki T, Natsume K, Takeuchi H, Quadt C, Shirao K, Minami H.

Cancer Chemother Pharmacol. 2019 Feb;83(2):289-299. doi: 10.1007/s00280-018-3725-2. Epub 2018 Nov 16.

47.

H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells.

Sasaki N, Toyoda M, Yoshimura H, Matsuda Y, Arai T, Takubo K, Aida J, Ishiwata T.

Oncotarget. 2018 Oct 5;9(78):34719-34734. doi: 10.18632/oncotarget.26176. eCollection 2018 Oct 5.

48.

Bone marrow-derived mesenchymal stem cells inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia after arterial injury in rats.

Iso Y, Usui S, Toyoda M, Spees JL, Umezawa A, Suzuki H.

Biochem Biophys Rep. 2018 Oct 24;16:79-87. doi: 10.1016/j.bbrep.2018.10.001. eCollection 2018 Dec.

49.

Renal effects of sodium glucose co-transporter 2 inhibitors in Japanese type 2 diabetes mellitus patients with home blood pressure monitoring.

Kobayashi K, Toyoda M, Kimura M, Hatori N, Furuki T, Sakai H, Takihata M, Umezono T, Ito S, Suzuki D, Takeda H, Kanamori A, Degawa H, Yamamoto H, Machimura H, Mokubo A, Chin K, Obana M, Hishiki T, Aoyama K, Nakajima S, Umezawa S, Shimura H, Aoyama T, Sato K, Miyakawa M.

Clin Exp Hypertens. 2019;41(7):637-644. doi: 10.1080/10641963.2018.1529778. Epub 2018 Oct 29.

PMID:
30373408
50.

Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney disease.

Kobayashi K, Toyoda M, Kimura M, Hatori N, Furuki T, Sakai H, Takihata M, Umezono T, Ito S, Suzuki D, Takeda H, Kanamori A, Degawa H, Yamamoto H, Machimura H, Mokubo A, Chin K, Obana M, Hishiki T, Aoyama K, Nakajima S, Umezawa S, Shimura H, Aoyama T, Sato K, Miyakawa M.

Diab Vasc Dis Res. 2019 Jan;16(1):103-107. doi: 10.1177/1479164118802759. Epub 2018 Oct 4.

PMID:
30284913

Supplemental Content

Loading ...
Support Center